Benecchi Christopher 4
4 · Sage Therapeutics, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Benecchi Christopher
Chief Operating Officer
Transactions
- Award
Common Stock
2025-01-16+20,000→ 44,737 total - Award
Stock Options (Right to buy)
2025-01-16+40,000→ 40,000 totalExercise: $6.97Exp: 2035-01-16→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Consists of shares of common stock issuable under 20,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.
- [F2]The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 10,000 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 30,000 shares vesting in 36 equal monthly installments thereafter.